Walgreen to pay more than $2.85 million to settle US overbilling charges

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Walgreen to pay more than $2.85 million to settle US overbilling charges

, Reuters - 1:28 PM ET 3/27/2025 default

(Reuters) -Walgreen will pay more than $2.85 million to settle whistleblower allegations that the pharmacy overbilled Medicaid programs in Georgia and Massachusetts for generic medications, the U.S. Department of Justice said on Thursday.

The settlement partially resolves claims against the Walgreens Boots Alliance ( WBA ) unit brought under the federal, Georgia and Massachusetts False Claims Act.

Walgreen pharmacies were accused of having from 2008 to 2023 submitted elevated "usual and customary" prices for some generic medications to the MassHealth and Georgia Medicaid programs, causing those programs to pay more for the medications than they should have.

(Reporting by Jonathan Stempel in New York)

(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.